Press Room

 

CAPD Statement on Senate Finance Committee Insulin Report

Washington, D.C., January 23, 2021 – Today, the Coalition for Affordable Prescription Drugs released the following statement regarding the report…

CAPD Statement on PCMA Legal Action Against Trump Administration’s Rebate Rule

Washington, D.C., January 12, 2021 – Today, the Coalition for Affordable Prescription Drugs released the following statement regarding the legal…

Forbes: The Challenges of Prescription Pricing For Seniors in the U.S.

This article was published in Forbes on December 29, 2020 By Gregory Gurbikian How drug companies price medications…

Rebate Rule Raises Seniors’ Medicare Premiums to Pay for Pharmaceutical Industry Windfall

Washington, D.C., November 20, 2020 – Today, the Coalition for Affordable Prescription Drugs released the following statement regarding the Trump…

Stakeholders Agree: Finalizing Trump Administration Rebate Rule Will Lead to Premium Increases for Seniors

Today, the Coalition for Affordable Prescription Drugs released the following statement regarding news that the Trump Administration is expected to finalize the…

CAPD Statement on Drug Companies’ Proposal to the White House

Today, the Coalition for Affordable Prescription Drugs released the following statement: “The ‘deal’ drug companies sent to the Administration…

CAPD Statement on the Administration’s Executive Order on Rebates

Today, the Coalition for Affordable Prescription Drugs released the following statement regarding the Administration’s new Executive Order on…

CAPD Comment Letter on CMS Rule on Drug Utilization Review and Value-Based Purchasing (2482-P)

Monday, July 20, 2020 Seema Verma, AdministratorCenters for Medicare and Medicaid ServicesDepartment of Health and Human ServicesAttention: CMS-2482-PP.O….